Prognostic and predictive value of epidermal growth factor receptor tyrosine kinase domain mutation status and gene copy number for adjuvant chemotherapy in non-small cell lung cancer.
about
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for MolecularPrognostic value of epidermal growth factor receptor mutations in resected non-small cell lung cancer: a systematic review with meta-analysisPrognostic factors in resected lung carcinomas.Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for MolecularSelection of chemotherapy for non-small cell lung cancer is facilitated by new therapeutic strategies.How close are we to customizing chemotherapy in early non-small cell lung cancer?The relationship between TTF-1 expression and EGFR mutations in lung adenocarcinomas.Are we ready to use biomarkers for staging, prognosis and treatment selection in early-stage non-small-cell lung cancer?Pretreatment levels of the serum biomarkers CEA, CYFRA 21-1, SCC and the soluble EGFR and its ligands EGF, TGF-alpha, HB-EGF in the prediction of outcome in erlotinib treated non-small-cell lung cancer patientsEGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII).Adjuvant Therapy of Resected Non-small Cell Lung Cancer: can We Move Forward?Oncogenic driver mutations in lung cancer.Clinical Significance of C-MET Overexpression and Epidermal Growth Factor Receptor Mutation in Platinum-Based Adjuvant Chemotherapy Outcome in Surgically Resected Lung Adenocarcinoma.The detection of EGFR mutation status in plasma is reproducible and can dynamically predict the efficacy of EGFR-TKI.Poor cell block adequacy rate for molecular testing improved with the addition of Diff-Quik-stained smears: Need for better cell block processing.Cytotoxicity of allitinib, an irreversible anti-EGFR agent, in a large panel of human cancer-derived cell lines: KRAS mutation status as a predictive biomarker.Predictive Tumor Biomarkers for EGFR InhibitorsPrognostic value of and in resected non-small cell lung cancer: a systematic review and meta-analysisCan sensitivity to cytotoxic chemotherapy be predicted by biomarkers?
P2860
Q26828860-64E20623-02B8-4118-B549-D158DEDE856AQ27692669-94982F66-4063-45FE-A6DE-48604B9BD434Q33697964-760F0589-82DB-41F6-B549-97F7081D6D35Q34159011-03141631-CED4-427C-825F-292DE9A8ABA5Q34769741-52727D19-D7A6-4C4F-BF5A-FCF4E4A61043Q35146944-7C193217-9788-4DF3-8F71-4310A0113FD7Q35151853-491BE156-18E5-440F-98BD-453EC1BFB312Q35200402-A3F1AA2A-A5F1-4EA1-855B-90129373F127Q35478632-AC9F7B4F-FE52-4DE4-BF7A-258B140BFB3EQ36250691-21518F19-1A0F-4557-AAA0-795008D92790Q38831491-AC5B08C2-5ADA-44DA-8E40-2B4BFD422B12Q38846405-9710045D-9AF9-4932-9678-11758F3475A2Q39328954-C84EA245-DB30-4493-B2F9-93165428AF69Q50050305-EBCF34A8-EAE2-405B-87A3-7F97ADFF3960Q50214316-D16EA86B-0240-4690-8B5B-08CF3AAC43FDQ55028849-5E84A2EC-E3E0-4E85-9C14-645ABC648449Q57896476-0186CCE7-6F13-468A-B4F6-58D3961AC38BQ58754535-C40E852E-827C-42EE-AA4F-CD6D79243006Q59274014-25F7B99E-EBF0-4FA9-AA0B-8C1771C015BB
P2860
Prognostic and predictive value of epidermal growth factor receptor tyrosine kinase domain mutation status and gene copy number for adjuvant chemotherapy in non-small cell lung cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Prognostic and predictive valu ...... in non-small cell lung cancer.
@ast
Prognostic and predictive valu ...... in non-small cell lung cancer.
@en
type
label
Prognostic and predictive valu ...... in non-small cell lung cancer.
@ast
Prognostic and predictive valu ...... in non-small cell lung cancer.
@en
prefLabel
Prognostic and predictive valu ...... in non-small cell lung cancer.
@ast
Prognostic and predictive valu ...... in non-small cell lung cancer.
@en
P2093
P2860
P1476
Prognostic and predictive valu ...... in non-small cell lung cancer.
@en
P2093
Akira Sakurada
Aurélie Le Maître
David H Johnson
Frances A Shepherd
James R Rigas
Keyue Ding
Lesley Seymour
Olga Ludkovski
Sarit Aviel-Ronen
P2860
P304
P356
10.1097/JTO.0B013E3181FD83A4
P577
2011-01-01T00:00:00Z